BJA Advance Access published online on June 17, 2005
British Journal of Anaesthesia, doi:10.1093/bja/aei169
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anaesthesiology, University Hospital Lausanne, Lausanne, Switzerland
* To whom correspondence should be addressed. Trauma is a serious global health problem, accounting for approximately one in 10 deaths worldwide. Uncontrollable bleeding accounts for 39% of trauma-related deaths and is the leading cause of potentially preventable death in patients with major trauma. While bleeding from vascular injury can usually be repaired surgically, coagulopathy-related bleeding is often more difficult to manage and may also mask the site of vascular injury. The causes of coagulopathy in patients with severe trauma are multifactorial, including consumption and dilution of platelets and coagulation factors, as well as dysfunction of platelets and the coagulation system. The interplay between hypothermia, acidosis and progressive coagulopathy, referred to as the lethal triad, often results in exsanguination. Current management of coagulopathy-related bleeding is based on blood component replacement therapy. However, there is a limit on the level of haemostasis that can be restored by replacement therapy. In addition, there is evidence that transfusion of red blood cells immediately after injury increases the incidence of post-injury infection and multiple organ failure. Strategies to prevent significant coagulopathy and to control critical bleeding effectively in the presence of coagulopathy may decrease the requirement for blood transfusion, thereby improving clinical outcome of patients with major trauma.
Review Article
Coagulopathy and blood component transfusion in trauma
2 Department of Anaesthesiology of the University Hospital, RWTH, Aachen, Germany
D. R. Spahn, E-mail: donat.spahn{at}chuv.hospvd.ch
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. T. Sartori, S. Imbergamo, E. Zanon, G. Bonaccorso, G. Pittoni, P. Feltracco, C. Ori, A. Pagnan, and G. Cella Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center Clinical and Applied Thrombosis/Hemostasis, December 1, 2009; 15(6): 628 - 635. [Abstract] [PDF] |
||||
![]() |
B. H. Shaz, C. J. Dente, R. S. Harris, J. B. MacLeod, and C. D. Hillyer Transfusion Management of Trauma Patients Anesth. Analg., June 1, 2009; 108(6): 1760 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dickneite and I. Pragst Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model Br. J. Anaesth., March 1, 2009; 102(3): 345 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fenger-Eriksen, M. Lindberg-Larsen, A. Q. Christensen, J. Ingerslev, and B. Sorensen Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations Br. J. Anaesth., December 1, 2008; 101(6): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hedner and M. Ezban Recent advances in clot biology and assessment of clotting Trauma, October 1, 2008; 10(4): 261 - 270. [Abstract] [PDF] |
||||
![]() |
J. B. A. MacLeod Trauma and Coagulopathy: A New Paradigm to Consider Arch Surg, August 1, 2008; 143(8): 797 - 801. [Full Text] [PDF] |
||||
![]() |
A. Levrat, A. Gros, L. Rugeri, K. Inaba, B. Floccard, C. Negrier, and J.-S. David Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients Br. J. Anaesth., June 1, 2008; 100(6): 792 - 797. [Abstract] [Full Text] [PDF] |
||||




